United States· US:84428-103_2eb5926c-e9dd-59f9-e063-6294a90aae44
Tuberculosis Eliminator
A medicinal product containing ginsenoside compound k, registered in United States by Hainan Zehuitang Biotechnology Co., LTD.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GINSENOSIDE COMPOUND K
- Manufacturer
- Hainan Zehuitang Biotechnology Co., LTD
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 2
- ndc1184428-103-02
- ndc1184428103027 BOTTLE in 1 BOX (84428-103-02) / 50 g in 1 BOTTLE (84428-103-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d11126e6-985f-45e5-a312-f57c9a3dd785 GET /v1/drugs/d11126e6-985f-45e5-a312-f57c9a3dd785?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "GINSENOSIDE COMPOUND K",
"productndc": "84428-103",
"dosage_form": "GRANULE",
"dea_schedule": null,
"strength_unit": "mg/10g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about ginsenoside compound k.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.